Irvine, Calif. and New York, N.Y. – June 13, 2023 – Integrated Medical Sensors (“IMS”), a medical device company developing innovative analyte monitoring tools to transform how we monitor and manage chronic diseases like diabetes, is pleased to announce a collaboration with JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization. 

IMS is leveraging its revolutionary semiconductor-based biosensing technology, nanotechnology, and electrochemistry to create a pipeline of continuous health monitoring products. These devices are designed to empower users and clinicians with real-time insights into a user’s health to minimize the burden of chronic diseases such as T1D. 

The award from JDRF supports IMS’s focus on developing continuous diabetes monitoring devices to monitor glucose, ketones, lactate, and other analytes of interest, using a single multiplexing sensor applied via traditional transdermal applicator technology. This innovative technology enables a single hair-thin sensor to provide multi-analyte continuous diabetes monitoring. The IMS device is easy to apply and wear and enables holistic metabolic control. In addition to funding, JDRF is also contributing strategic support through its deep expertise and vast network in the diabetes field. 

“JDRF is committed to accelerating development of devices that improve health outcomes and quality of life for people with type one diabetes,” said Jonathan Rosen, PhD, director of research at JDRF. “Diabetic ketoacidosis remains a critical risk for people with type one diabetes, and IMS’ continuous glucose and ketone monitoring technology has the potential to help prevent this dangerous acute complication by letting people know when their ketones are rising so they can take preventive action.” 

“Together with JDRF, we are aligned on the mission to develop a better monitoring solution for the millions of patients worldwide who are affected by diabetes and want to manage and monitor their health closely,” said Muhammad Mujeeb-U-Rahman, CEO at IMS. “This collaboration will help advance our cutting-edge continuous diabetes monitoring program, bring us past our current glucose-only human clinical trials, and closer to multianalyte human clinical studies.” 

About Integrated Medical Sensors 

Integrated Medical Sensors is a medical device company focused on improving diabetes care by developing the next generation of continuous diabetes monitoring products. IMS is using cutting-edge nanotechnology, semiconductor technology, electrochemistry, and biomaterials in partnership with leading researchers and innovators to tackle the biggest challenges in personal healthcare, starting with diabetes monitoring. Learn more at www.integratedmedicalsensors.com  

About JDRF  

JDRF’s mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally and globally for efficiency and broader fundraising impact, and uniting on a global stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement, and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq). 

About Type 1 Diabetes (T1D) 

T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all. This leads to dependence on insulin therapy and the risk of short or long-term complications, which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves, and heart; and even death if left untreated. Globally, it impacts nearly 9 million people. Many believe T1D is only diagnosed in childhood and adolescence, but diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The onset of T1D has nothing to do with diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.